ACUTE ADRENAL FAILURE—ADRENAL CRISIS

Definition and Importance

  • Acute adrenal failure (adrenal crisis) is an endocrine emergency, potentially fatal if untreated.
  • Dominant features: Dehydration and cardiovascular collapse (shock).

Clinical Settings for Adrenal Crisis

  1. Known Primary Adrenal Insufficiency
    • Omission of glucocorticoid therapy.
    • Inadequate dose increase during physical stress (e.g., infection, surgery).
  2. Undiagnosed Primary Adrenal Insufficiency
    • Undergoing major stress without prior recognition (acute infection, trauma, etc.).
  3. Necrosis of Adrenals
    • Intra-adrenal hemorrhage/infarction.
    • May be caused by infection, trauma, anticoagulant therapy, or coagulopathy.
  4. Secondary Adrenal Insufficiency (less common cause)
    • Intact mineralocorticoid secretion usually prevents crisis, but severe stress or abrupt withdrawal of high-dose exogenous glucocorticoids can precipitate.

Adrenal Hemorrhage

  • Consider in shock with infection, trauma, anticoagulation (heparin/warfarin), or coagulopathy (e.g., antiphospholipid syndrome).
  • Possible back/flank/abdominal pain from intra-adrenal bleeding.
  • Fulminant Meningococcemia: Hemorrhagic destruction of both adrenals → Waterhouse-Friderichsen syndrome (especially children/young adults).
    • Presents with purpura, meningitis, shock, DIC, purpura fulminans.

Clinical Presentation

  • Shock: Dehydration, hypotension (circulatory collapse).
  • Additional Symptoms: Anorexia, nausea, vomiting, abdominal pain, fever, confusion, lethargy.
  • Possible Preexisting Adrenal Failure signs: Hyperpigmentation, weight loss, hyponatremia, hyperkalemia.
  • Misdiagnosis Risk: Fever + abdominal pain can mimic an acute surgical abdomen → potentially disastrous unnecessary surgery.

Empiric Treatment

  • Consider in severely ill patients with shock refractory to fluids and pressors.
  • Do not delay therapy for diagnostic test results if adrenal crisis is suspected.

Treatment for Adrenal Crisis

  1. Glucocorticoid Replacement
    • Hydrocortisone sodium succinate: 100 mg IV bolus initially.
    • Continue 100 mg IV q6–8h until resolution of precipitating illness, then taper.
  2. Volume Repletion
    • Dextrose in isotonic saline (2–4 L over 4 hours), adjusted for comorbidities and response.
  3. Identify Underlying Cause
    • Search for infection, hemorrhage, infarction, or other triggers.
  4. Monitoring
    • Frequent checks of serum electrolytes, acid–base status, glucose, renal function.
Addison’s disease

CHRONIC ADRENAL INSUFFICIENCY

Rate and Extent of Adrenal Destruction

  • >90% cortical destruction needed for overt clinical insufficiency.
  • Slow Progression: May remain subclinical until precipitated by stress (infection, trauma, surgery).

Signs and Symptoms

  • Both Glucocorticoid & Mineralocorticoid Deficiency (Primary Failure):
    • Fatigue, generalized weakness, diffuse myalgias, arthralgias.
    • Anorexia, weight loss, nausea, vomiting, abdominal pain.
    • Psychiatric changes (irritability, depression, apathy).
    • Postural hypotension, hyperpigmentation, salt craving.
    • Hyponatremia, hyperkalemia, mild normocytic anemia.
    • Hypoglycemia (more common in children).
  • Hyperpigmentation:
    • Increased ACTH → MSH effect.
    • Darkening of friction areas (knees, knuckles, elbows), belt line, scars, inner lip surfaces, palmar creases, areola, freckles.
    • Vitiligo (~20% of autoimmune Addison’s) from autoimmune destruction of melanocytes.

Gender-Specific

  • Women: Loss of axillary & pubic hair, ↓libido due to low adrenal androgens.
  • Men: Testicular androgens → minimal androgen deficiency signs.

Etiologies of Primary Adrenal Failure

  1. Autoimmune Adrenalitis (~80% in developed countries).
  2. Infections (tuberculosis historically; fungal, HIV).
  3. Metastatic Cancer (e.g., lung, breast, melanoma).
  4. Adrenal Hemorrhage (trauma, antiphospholipid syndrome).
  5. Adrenoleukodystrophy.
  6. Bilateral Adrenalectomy.
  7. Drug-Induced (mitotane, ketoconazole).
  8. Congenital (adrenal hypoplasia e.g., DAX1 or SF-1 mutations).

Autoimmune Associations

  • 21-Hydroxylase Antibodies: Nearly universal in autoimmune Addison’s.
  • Polyglandular Autoimmune Syndrome Type II (APS2):
    • Addison’s + autoimmune thyroid disease + type 1 diabetes mellitus.
    • More common in women, onset 20–40 years old.
  • Polyglandular Autoimmune Syndrome Type I (APS1):
    • Rare, autosomal recessive (AIRE gene mutations).
    • Triad: Hypoparathyroidism, chronic mucocutaneous candidiasis, Addison’s.

LABORATORY FINDINGS AND TREATMENT OF PRIMARY ADRENAL INSUFFICIENCY

Lab Findings

  • Low Cortisol, High ACTH.
  • Hyponatremia, Hyperkalemia (loss of aldosterone).
  • Mild metabolic acidosis, azotemia from volume depletion.
  • Low DHEA-S, androstenedione → female loss of body hair.
  • Cosyntropin Stimulation Test: No significant rise in cortisol.

Treatment Principles

  1. Glucocorticoid Replacement
    • Hydrocortisone, cortisone acetate, or prednisone.
    • Stress Dosing for major infections, surgery, trauma (2–3× usual dose).
  2. Mineralocorticoid Replacement
    • Fludrocortisone (50–200 µg daily) to normalize serum K⁺, Na⁺, BP.
    • Adjust dose by checking for hypokalemia, edema, or persistent hyperkalemia/hyponatremia.
  3. Patient Education
    • Dose adjustments during illness, use of IM injection if vomiting.
    • Medical identification (bracelet/card “adrenal insufficiency—give cortisone”).
    • Keep emergency dexamethasone syringes for self-injection.

Perioperative Management

  • Surgery with General Anesthesia: Stress dose coverage (e.g., methylprednisolone 20–40 mg IM pre-op, taper over 2–3 days).
  • No Additional Mineralocorticoid typically needed until oral intake resumes.

LABORATORY FINDINGS AND TREATMENT OF SECONDARY ADRENAL INSUFFICIENCY

Key Distinctions from Primary

  1. No Hyperpigmentation: ACTH is low/normal (no MSH effect).
  2. Aldosterone Levels usually normal (RAAS intact) → minimal hyperkalemia or salt craving.
  3. Possible Hyponatremia: due to impaired free-water excretion, elevated vasopressin.
  4. May Present with pituitary/hypothalamic mass symptoms or other pituitary hormone deficits (e.g., hypothyroidism, hypogonadism).

Lab Findings

  • Low Cortisol, Low/Undetectable ACTH → diagnosing certain if cortisol <5 µg/dL at 8 am with severely low ACTH.
  • Cosyntropin Stimulation may show a delayed rise but peak <18 µg/dL.

Treatment

  1. Glucocorticoid Replacement
    • No mineralocorticoid needed (aldosterone normal).
    • Hydrocortisone or equivalent, often 2/3 AM, 1/3 PM dosing.
  2. Avoid Over- or Undertreatment
    • Monitor clinical signs.
  3. Stress Dosing for severe illness or surgery.
  4. If Additional Pituitary Deficits: Manage hypothyroidism, hypogonadism, etc. after ensuring adequate cortisol replacement.

Join the
MyEndoConsult Community

We are grateful to the contribution of authors just like you

The MyEndoconsult Team. A group of physicians dedicated to endocrinology and internal medicine education. Learn more about our team

Current Progress
Current Progress
Current Progress
Current Progress
>